What measures can health businesses implement to tackle antibiotic resistance while ensuring the continued development of new antimicrobial treatments?

ANSWER: Health businesses can address antibiotic resistance by implementing strict infection prevention protocols, promoting appropriate antibiotic use through stewardship programs, investing in rapid diagnostic tools to guide precise treatment, and supporting research and development of new antimicrobials. Collaborating with policymakers for incentives, fostering public education on responsible antibiotic use, and partnering with academic institutions for innovative research can further bolster these efforts.